Clinical Trial Update: Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study of rifaximin vaginal tablets for bacterial vaginosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• rifaximin vaginal tablets (rifaximin)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: BACTERIAL VAGINOSIS | Phase 2 | Status: TERMINATED